These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11342209)

  • 1. An unknown FVIII-inactivating substance derived from endothelial cells inhibits the intrinsic tenase complex.
    Bombeli T; Woodtli K; Haeberli A
    Thromb Res; 2001 Jan; 101(2):83-9. PubMed ID: 11342209
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
    Nogami K; Shima M; Nishiya K; Hosokawa K; Saenko EL; Giddings JC; Tanaka I; Yoshioka A
    Br J Haematol; 2002 Mar; 116(4):868-74. PubMed ID: 11886394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
    Li J; Li S; Yan L; Ding T; Linhardt RJ; Yu Y; Liu X; Liu D; Ye X; Chen S
    Eur J Med Chem; 2017 Oct; 139():191-200. PubMed ID: 28800457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of thrombin and factor Xa with bovine vascular endothelial cells, smooth muscle cells and rat hepatoma cells.
    Dryjski M; Kuo BS; Bjornsson TD
    Thromb Haemost; 1988 Oct; 60(2):148-52. PubMed ID: 3217915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin.
    Owen BA; Owen WG
    Biochemistry; 1990 Oct; 29(40):9412-7. PubMed ID: 2248954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel inhibitor of factor X activation from the salivary glands of the bed bug Cimex lectularius.
    Valenzuela JG; Guimaraes JA; Ribeiro JM
    Exp Parasitol; 1996 Jul; 83(2):184-90. PubMed ID: 8682187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
    Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation, activity and inactivation of factor VIII in factor VIII products.
    Orfeo T; Elsman R; Gissel M; Mann KG; Butenas S
    Haemophilia; 2016 May; 22(3):462-73. PubMed ID: 26822998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
    Matsumoto T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DX-9065a inhibition of factor Xa and the prothrombinase complex: mechanism of inhibition and comparison with therapeutic heparins.
    Rezaie AR
    Thromb Haemost; 2003 Jan; 89(1):112-21. PubMed ID: 12540961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
    Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody to VEGF upregulates factor VIII via interleukin-1 in activated adrenal cortex-derived capillary endothelial cells.
    Li W; Keller GA
    Int Immunopharmacol; 2003 Apr; 3(4):493-512. PubMed ID: 12689655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.
    Herault JP; Bono F; Avril C; Schaeffer P; Herbert JM
    Biochem Pharmacol; 1999 Mar; 57(6):603-10. PubMed ID: 10037444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DX-9065a inhibits proinflammatory events induced by gingipains and factor Xa.
    Matsushita K; Imamura T; Tomikawa M; Tancharoen S; Tatsuyama S; Maruyama I
    J Periodontal Res; 2006 Apr; 41(2):148-56. PubMed ID: 16499718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium.
    Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
    Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
    Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of factor VIIIa in the intrinsic factor Xase.
    Fay PJ
    Thromb Haemost; 1999 Aug; 82(2):193-200. PubMed ID: 10605704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.